A Win For Miragen Therapeutics, Inc.

Mon 27 Jan 20 at 05:30 PM
A Win For Miragen Therapeutics, Inc.

Miragen Therapeutics, Inc. (MGEN:NASDAQ) jumped higher at $1.46, a gain of 50.5%. On Fri 24 Jan 20, MGEN:NASDAQ touched a New 2-Week High of $0.97. The stock got featured on our News Catalysts scanner on Thu 23 Jan 20 at 09:35 AM in the 'BIOTECH' category. From Fri 03 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days

The stock spiked on Fri 24 Jan 20 at $1.4 with a volume of 21M+.

About Miragen Therapeutics, Inc. (MGEN:NASDAQ)

Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.